Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD

Avery RL, Pieramici DJ, Rabena MD et al. (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363–372

Bakri SJ, Patel SP (2006) Retinal pigment epithelial tear following intravitreal bevacizumab. Eye 22; Epub ahead of print

Bartz-Schmidt KU, Holz FG (2006) Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration. Ophthalmologe 103:461–462

Bressler NM, Finkelstein D, Sunness JS et al. (1990) Retinal pigment epithelial tears through the fovea with preservation of good visual acuity. Arch Ophthalmol 108:1694–1697

Casswell AG, Kohen D, Bird AC (1985) Retinal pigment epithelial detachments in the elderly: classification and outcome. Br J Ophthalmol 69:397–403

Chakravarthy U, Adamis AP, Cunningham ET Jr et al. (2006) Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration. Ophthalmology 113:1508.e1–1525

Coscas G, Koenig F, Soubrane G (1990) The pretear characteristics of pigment epithelial detachments: a study of 40 eyes. Arch Ophthalmol 108:1687–1693

D’Amico DJ VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group; Patel M, Adamis AP, Cunningham ET Jr, Guyer DR, Katz B (2006) Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. Ophthalmology 113:1001.e1–1006

Dhalla MS, Blinder KJ, Tewari A et al. (2006) Retinal pigment epithelial tear following intravitreal pegaptanib sodium. Am J Ophthalmol 141:752–754

Freeman WR, Falkenstein I (2006) Avastin and new treatments for AMD: where are we? Retina 26: 853–858

Gass JDM (1984) Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 68:513–519

Gass JDM (1984) Retinal pigment epithelial rip during krypton red laser photocoagulation. Am J Ophthalmol 98:700–706

Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU (2006) Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration. Acta Ophthalmol Scand 84: 833–834

Gragoudas ES, Adamis AP, Cunningham ET Jr et al. (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816

Hoskin A, Bird AC, Sehmi K (1981) Tears of detached retinal pigment epithelium. Br J Ophthalmol 65: 417–422

Jaissle GB, Szurman P, Bartz-Schmidt, KU (2005) Empfehlung für die Durchführung von intravitrealen Injektionen. Stellungnahme der Retinologischen Gesellschaft, der Deutschen Ophthalmologischen Gesellschaft (DOG) und des Berufsverbandes der Augenärzte Deutschlands (BVA). Klin Monatsbl Augenheilkd 222:390–395

Krishnan NR, Chandra SR, Stevens TS (1985) Diagnosis and pathogenesis of retinal pigment epithelial tears. Am J Ophthalmol 100:698–707

Ladewig MS, Ziemssen F, Jaissle G et al. (2006) Intravitreal bevacizumab for neovascular age-related macular degeneration. Ophthalmologe 103:463–470

Mennel S, Callizo J, Schmidt JC, Meyer CH (2007) Acute retinal pigment epithelial tear in the untreated fellow eye following repeated bevacizumab (Avastin trademark) injections. Acta Ophthalmol Scand Apr 2; [Epub ahead of print]

Meyer CH, Mennel S, Schmidt JC, Kroll P (2006) Acute retinal pigment epithelial tear following intravitreal bevacizumab (Avastin) injection for occult choroidal neovascularisation secondary to age related macular degeneration. Br J Ophthalmol 90:1207–1208

Michels S, Aue A, Simader C et al. (2006) Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. Am J Ophthalmol 141: 396–398

Michels S, Rosenfeld PJ, Puliafito CA et al. (2005) Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112:1035–1047

Nicolo M, Ghiglione D, Calabria G (2006) Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin). Eur J Ophthalmol 16:770–773

Panagiotidis D, Karagiannis DA, Baltatzis S (2006) Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 16:326–329

Pauleikhoff D, Löffert D, Spital G et al. (2002) Pigment epithelial detachment in the elderly. Graefe’s Arch Clin Exp Ophthalmol 240:533–538

Pece A, Introini U, Bottoni F et al. (2001) Acute retinal pigment epithelial tear after photodynamic therapy. Retina 21:661–665

Rosenfeld PJ, Heier JS, Hantsbarger G et al. (2006) Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 113: 623–632

Schoeppner G, Chuang EL, Bird AC (1989) The risk of fellow eye visual loss with unilateral retinal pigment epithelial tears. Am J Ophthalmol 108:683–685

Schrader WF (2006) Age-related macular degeneration: a socioeconomic time bomb in our aging society. Ophthalmologe 103:742–748

Shah CP, Hsu J, Garg SJ et al. (2006) Retinal pigment epithelial tear after intravitreal bevacizumab injection. Am J Ophthalmol 142:1070–1072

Singh RP, Sears JE (2006) Retinal pigment epithelial tears after pegaptanib injection for exudative age-related macular degeneration. Am J Ophthalmol 142:160–162

Spaide RF, Laud K, Fine HF et al. (2006) Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 26:383–390

Spandau UH, Jonas JB (2006) Retinal pigment epithelium tear after intravitreal bevacizumab for exudative age-related macular degeneration. Am J Ophthalmol 142: 1068–1070

Srivastava SK, Sternberg P Jr (2002) Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia. Retina 22:669–671

Völker M, Peters S, Inhoffen W et al. (2006) Early antiexudative response OCT monitoring after intravitreal bevacizumab injection. Ophthalmologe 103: 476–483

Yeo JH, Marcus S, Murphy RP (1988) Retinal pigment epithelial tears. Patterns and prognosis. Ophthalmology 95:8–13

Yoshitani S, Katsura M, Minamoto A et al. (2003) Retinal pigment epithelial tear involving the fovea with preserved visual function. Ophthalmic Surg Lasers Imaging 34:217–220

Ziemssen F, Bartz-Schmidt KU, Grisanti S (2006) (Side) effects of VEGF inhibition. Ophthalmologe 103:484–492